DaVita to lose money on sale of medical group in order to speed up closing The Citizen 7 years ago The company lowered the sale price of its medical group by $560 million. Source: The Business Journal Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Lovelace Medical Group CEO to retireDateAugust 4, 2023In relation toPolvaderaLovelace Medical Group names new COODateOctober 28, 2024In relation toPolvaderaChicago investment group launches $50 million fund to acquire medical properties in New Mexico, other statesDateApril 25, 2022In relation toPolvadera
